DIGESTAID - Digestive Artificial Intelligence Development signed a Memorandum of Understanding with SDCI - Strategic Deals Company for Investment (SDCI) in Saudi Arabia on 31 August 2026.

DIGESTAID – Digestive Artificial Intelligence Development – is a company dedicated to the development of AI platforms with the aim of improving digestive healthcare. Our team of physicians, software engineers and data scientists strive to produce deep learning solutions for automatic detection and characterization of lesions across different fields of Gastroenterology and Digestive Endoscopy, supporting the physician in the decision process. Our highly motivated and multidisciplinary team mainly focus in a non-invasive AI lesion detection/differentiation software solution for the entirety of the digestive tube as well as pancreatobiliary lesion characterization. Our main goals are to improve diagnostic accuracy, reduce medical error, improve workflow efficiency, reduce costs while ultimately contributing to improve patient experience and outcome. Our motto is to provide higher accuracy in digestive endoscopy, improved medical decisions and to spare time and valuable health human resources